oral semaglutide cardiovascular outcomes soul trial results 2024 2025 Updates in Medicine on X: "SOUL (NEJM 2025): led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in Semaglutide cardiovascular outcomes align more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12






















![Wolfwillow Haven [Jumpstart 2022] SWSH189](https://cdn.shopify.com/s/files/1/0824/7345/1830/files/b6594747-cd27-523c-a88b-fa39b754d9c3.png?v=1771539289)


